CHE — Chemed Corp stock price and chart

Share this page

CHE

$512.38-0.59%

as of close, Oct 16, 2026

☾ AH $512.38 -0.59%

Chemed CorpStock · HealthcareRussell 1000 0.009%US Stock Market 0.009%Russell 3000 0.008%

PeersMRNALLYMDTUNHJNJTMO

Technical analysis2

Overlay lines0

Addendum charts0

VolumeDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEDDEEDED

20162019202120242026

150.0200.0250.0300.0350.0400.0450.0500.0550.0600.002.0M$512.38

2026-10-16

Price$512.38

MA20$487.66

MA50$454.34

Vol717.2K

What would $1,000 invested in CHE be worth today? →

CHE returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $512.38
YTD price return: +19.75%
YTD total return: +20.23%
Next earnings: Oct 27, 2026 · After close
Market cap: 6.7B2016-12 2.6B2026-10 6.7B+157.2% over the window
Enterprise value: 7B
Shares outstanding: 13.1M2016-06 16.2M2026-06 13.1M-19.3% over the window
52W low: $365.21
52W high: $557.00
From 52W high: -8.01%
From 52W low: +40.30%
52W range: 77%

Volume

Rel volume: 0.61×
30D volume: 147.4K
30D $ vol: 74.8M

Fundamentals

Sales (ttm): 2.6B2016-06 1.6B2026-06 2.6B+65.7% over the window
Sales/share: $198.552016-06 $96.702026-06 $198.55+105.3% over the window
EPS (ttm): $19.902016-06 $6.312026-06 $19.90+215.6% over the window
FCF (ttm): 323.6M2016-06 130M2026-06 323.6M+148.9% over the window
FCF/share: $24.762016-06 $8.032026-06 $24.76+208.3% over the window
Book value/share: $63.542016-06 $28.512026-06 $63.54+122.9% over the window
Net margin: 10.60%2016-06 6.9%2026-06 10.6%+52.9% over the window
ROE: 33.11%2016-06 23.5%2026-06 33.1%+40.9% over the window
ROA: 17.41%2016-06 12.7%2026-06 17.4%+36.9% over the window
Debt / equity: 0.17×2016-06 0.302026-06 0.17-44.4% over the window
Current ratio: 0.912016-06 0.882026-06 0.91+3.7% over the window

Growth (CAGR, ttm) · 10Y

Sales: +3.31%2025-06-30 → 2026-06-302.5B → 2.6B (+3.3% total)+5.86%2023-06-30 → 2026-06-302.2B → 2.6B (+18.7% total)+4.12%2021-06-30 → 2026-06-302.1B → 2.6B (+22.3% total)+5.18%2016-06-30 → 2026-06-301.6B → 2.6B (+65.7% total)
Net income: -5.29%2025-06-30 → 2026-06-30290.3M → 275M (-5.3% total)+6.68%2023-06-30 → 2026-06-30226.5M → 275M (+21.4% total)-1.95%2021-06-30 → 2026-06-30303.4M → 275M (-9.4% total)+9.75%2016-06-30 → 2026-06-30108.5M → 275M (+153.5% total)
FCF: -12.87%2025-06-30 → 2026-06-30371.4M → 323.6M (-12.9% total)+4.96%2023-06-30 → 2026-06-30279.9M → 323.6M (+15.6% total)+2.70%2021-06-30 → 2026-06-30283.3M → 323.6M (+14.2% total)+9.55%2016-06-30 → 2026-06-30130M → 323.6M (+148.9% total)
Shares: -10.31%2025-06-30 → 2026-06-3014.6M → 13.1M (-10.3% total)-4.65%2023-06-30 → 2026-06-3015.1M → 13.1M (-13.3% total)-3.64%2021-06-30 → 2026-06-3015.7M → 13.1M (-16.9% total)-2.12%2016-06-30 → 2026-06-3016.2M → 13.1M (-19.3% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: +2.15%2025-06-30 → 2026-06-30$19.48 → $19.90 (+2.2% total)+9.89%2023-06-30 → 2026-06-30$14.99 → $19.90 (+32.7% total)+1.32%2021-06-30 → 2026-06-30$18.64 → $19.90 (+6.8% total)+12.18%2016-06-30 → 2026-06-30$6.31 → $19.90 (+215.6% total)
Sales/share: +15.19%2025-06-30 → 2026-06-30$172.38 → $198.55 (+15.2% total)+11.03%2023-06-30 → 2026-06-30$145.07 → $198.55 (+36.9% total)+8.05%2021-06-30 → 2026-06-30$134.84 → $198.55 (+47.2% total)+7.46%2016-06-30 → 2026-06-30$96.70 → $198.55 (+105.3% total)
FCF/share: -2.86%2025-06-30 → 2026-06-30$25.49 → $24.76 (-2.9% total)+10.07%2023-06-30 → 2026-06-30$18.56 → $24.76 (+33.4% total)+6.57%2021-06-30 → 2026-06-30$18.01 → $24.76 (+37.5% total)+11.92%2016-06-30 → 2026-06-30$8.03 → $24.76 (+208.3% total)
Book value/share: -22.75%2025-06-30 → 2026-06-30$82.25 → $63.54 (-22.7% total)+0.21%2023-06-30 → 2026-06-30$63.15 → $63.54 (+0.6% total)+2.80%2021-06-30 → 2026-06-30$55.35 → $63.54 (+14.8% total)+8.35%2016-06-30 → 2026-06-30$28.51 → $63.54 (+122.9% total)
Dividend/share: +20.01%2025-06-30 → 2026-06-30$2.00 → $2.40 (+20.0% total)+16.44%2023-06-30 → 2026-06-30$1.52 → $2.40 (+57.9% total)+12.03%2021-06-30 → 2026-06-30$1.36 → $2.40 (+76.5% total)+9.15%2016-06-30 → 2026-06-30$1.00 → $2.40 (+140.1% total)
Price: +18.92%2025-10-16 → 2026-10-16$430.92 → $512.38 (+18.9% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-0.09%2023-10-16 → 2026-10-16$513.80 → $512.38 (-0.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+3.56%2021-10-15 → 2026-10-16$430.12 → $512.38 (+19.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+13.86%2016-10-14 → 2026-10-16$139.80 → $512.38 (+266.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +19.55%2025-10-16 → 2026-10-16$428.63 → $512.38 (+19.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+0.32%2023-10-16 → 2026-10-16$507.49 → $512.38 (+1.0% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+3.94%2021-10-15 → 2026-10-16$422.29 → $512.38 (+21.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+14.30%2016-10-14 → 2026-10-16$134.61 → $512.38 (+280.7% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 25.7×2016-12 24.442026-10 24.34-0.4% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 19.2×2016-12 14.892026-10 19.17+28.8% over the window
Fwd P/E: 18.1×
P/S (ttm)Market cap ÷ TTM revenue.: 2.6×2016-12 1.662026-10 2.58+55.8% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 8.1×2016-12 5.342026-10 8.06+50.9% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 20.7×2016-12 18.182026-10 20.69+13.8% over the window
EV/EBITDA (fy): 16.7×
EV/Sales (ttm): 2.7×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 4.83%2016-09 5.5%2026-06 5.3%-3.3% over the window
Dividend yield (fwd)Indicated annual dividend ÷ last close: the last regular payment × payments a year, from our own dividend record. Shown only for a company that pays the same amount each time (raises and cuts allowed), whose payments are on schedule and agree with the dividends it reports paying; a company whose payments vary in size, such as an unequal interim and final, has no forward figure — see the ttm yield.: 0.55%
Dividend yield (ttm)Dividends paid over the last year ÷ last close: the last full cycle of regular payments in our own dividend record. Below the forward yield after a raise, above it after a cut. Shown only when the record holds that full cycle and it agrees with the dividends the company reports paying; otherwise —.: 0.49%
Dividend/share (fwd)The indicated annual dividend: the last regular payment × payments a year, for a company that pays the same amount each time.: $2.80
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 13.1M ÷ 14.6M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: 10.31%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (10.31%) + dividends paid over that year ($33.2M) ÷ market_cap_at(2025-06-30) ($7.1B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 10.78%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($642.9M) ÷ today's market cap ($6.7B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 9.60%2016-09 4.8%2026-06 10.6%+120.0% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $642.9M + TTM dividends $33.2M) ÷ today's market cap ($6.7B). Same caveat as the cash buyback yield.: 10.10%2016-09 5.4%2026-06 11.1%+104.7% over the window

Vs own 10Y history

P/E: 22nd
P/OI: 24th
P/S: 24th
P/B: 42nd
P/FCF: 26th

Bar = where today’s multiple sits in CHE’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-16#

-0.59%

+2.51%

+0.48%

+2.17%

YTD

+19.75%

+18.90%

+19.12%

Financial statements

Open full CHE financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+10.48%	+0.43%
JNJ	Johnson & Johnson	-4.38%	+0.90%
ABBV	AbbVie Inc.	+8.73%	+0.71%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+6.97%	-1.29%
MRK	Merck & Co. Inc.	+0.72%	+0.52%
NVS	Novartis AG	+8.59%	+0.16%
TMO	Thermo Fisher Scientific Inc.	+6.41%	-0.93%
AMGN	Amgen Inc.	+14.92%	-0.35%

CHE — Chemed Corp price, chart and key statistics